Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits
This threshold is therefore lower than the average incretin effect previously described in youths with obesity and normal glucose tolerance (3)
BPC-157 is believed to work through multiple mechanisms, including upregulation of growth hormone receptors, modulation of nitric oxide synthesis, and interaction with the dopaminergic system
Youre adjusting
US$ 29.88
US$ 28.54
US$ 20.58
US$ 23.83
US$ 29.90
